Abstract:Abstract Background The global epidemiology of primary liver cancer (PLC), primarily hepatocellular carcinoma (HCC), has evolved significantly in the past decades because of improved control of viral hepatitis and the growing prevalence of metabolic factors. We conducted a quantitative forecast of the incidence and etiology of PLC. Methods Incidence rates of PLC were projected in two endemic Asian countries (Taiwan and Japan) and two Western countries (the United States and United Kingdom) with rigorous cancer registry. The annual incidence of PLC (ICD-10 C22.0) between 1980 and 2013 were obtained from the Taiwan Cancer Registry Database, the Japan National Cancer Center, the US SEER 9 database, Cancer Research UK, and the European Network of Cancer Registry. Incidence rates were projected to year 2035 by an age-period-cohort model with a power link function. The population attributable fractions (PAF) of chronic hepatitis B (HBV), chronic hepatitis C (HCV), alcohol consumption, obesity, and diabetes mellitus (DM) for HCC in Taiwan were projected to 2045. The prevalence of each risk factor was obtained from national surveys and projected inferentially by using a log-linear model or simple linear assumption. The relative risk of each factor was derived from pooled literature data. Results From 2013 to 2035, incidence rates of PLC in Taiwan are estimated to decrease by more than 50% in both men (49.3 to 24.2/100,000) and women (19.7 to 9.2/100,000). In Japan, incidence rates have plateaued in the 1990s, and are expected to continue to decline to 17.0/100,000 for men and 6.3/100,000 for women. Conversely, rates in the UK are projected to increase by more than 30% in both men (13.5 to 18.2/100,000) and women (6.0 to 8.1/100,000). A more modest increase is expected in the US, from 10.2 to 12.5/100,000 for men and 3.3 to 3.5/100,000 for women. In Taiwan, the PAF of HBV, the predominant risk factor of HCC, is predicted to decrease from 54.3% in 2015 to 34.4% in 2045. By 2045, the PAFs of obesity and DM are estimated to reach 11.9% and 15.4%, respectively, the latter similar to that of HCV (15.0%). Conclusion PLC incidence rates are forecast to follow a trend of convergence in four representative countries. Metabolic factors are expected to play increasingly important etiologic role in HCC even in regions currently endemic for viral hepatitis. Citation Format: Emily Han-Chung H. Hsiue, Wei-Cheng Lo, Hsien-Ho Lin, Chih-Hung Hsu, Ann-Lii Cheng. Forecast of the incidence and etiology of liver cancer in Taiwan, Japan, United States, and United Kingdom: toward harmonization of East and West [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 286. doi:10.1158/1538-7445.AM2017-286

Guideline for Stratified Screening and Surveillance in Patients with High Risk of Primary Liver Cancer (2020)

Risk stratification of primary liver cancer

Prospective Study of Early Detection for Primary Liver Cancer.

Evaluation of Surveillance for High-risk Population of Liver Cancer in Shanghai

Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990‐2017

Abstract 286: Forecast of the Incidence and Etiology of Liver Cancer in Taiwan, Japan, United States, and United Kingdom: Toward Harmonization of East and West

Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).

[Effect evaluation of the primary screening strategy for liver cancer in rural areas of China]

Incidence trends of primary liver cancer in different geographical regions of China from 1978 to 2012 and projections to 2032: An age‐period‐cohort analysis

Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study

China Guideline for Liver Cancer Screening (2022, Beijing)

Changed Clinical Aspects of Primary Liver Cancer in China During the Past 30 Years.

Global Trend of Aetiology-Based Primary Liver Cancer Incidence from 1990 to 2030: a Modelling Study

Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: Promoting the early detection of hepatocellular carcinoma in China

Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study

Characteristics and Prognosis of Primary Liver Cancer in Young Patients in China

Hepatocellular Cancer Surveillance in Patients with Advanced Chronic Liver Disease

[Changes of Clinical Aspect of Primary Liver Cancer in China During the Past 30 Years--control Study for 3,250 Cases with Primary Liver Cancer].

Global Trend of Aetioloy-Based Primary Liver Cancer Incidence from 1990 to 2030: A Modelling Study